Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Revenue

Jamjoom Pharmaceuticals Factory Company had revenue of 354.66M SAR in the quarter ending September 30, 2026, with 3.61% growth. This brings the company's total for the last twelve months to 1.59B, up 8.94% year-over-year. In the year 2025, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.50B with 13.82% growth. That makes Jamjoom Pharmaceuticals Factory Company the 12,255th largest company in the world by revenue and 109th in Saudi Arabia.

• Revenue (ttm): 1.59B
• Revenue Growth: +8.94%
• P/S Ratio: 5.04
• Revenue / Employee: n/a
• Employees: 1,255
• Market Cap: 7.99B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Products 1.28B 85.6%
• Consumer Health Products 216.77M 14.4%

By Geography

Chart

• Kingdom of Saudi Arabia 988.67M 65.9%
• Gulf 200.60M 13.4%
• Iraq 130.85M 8.7%
• North Africa and Other Export Markets 106.24M 7.1%
• Egypt 74.27M 4.9%

Fiscal year ended Dec 31, 2025 See the full TADAWUL:4015 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.50B	182.15M	13.82%
Dec 31, 2024	1.32B	217.66M	19.77%
Dec 31, 2023	1.10B	184.15M	20.09%
Dec 31, 2022	916.67M	180.99M	24.60%
Dec 31, 2021	735.68M	-69.63M	-8.65%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error